Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies.

Current opinion in infectious diseases - 1 Dec 2024

Zhu Violet Z, Horton Miles B, Haeusler Gabrielle M, Yong Michelle K

Abstract excerpt

PURPOSE OF REVIEW: Cytomegalovirus (CMV) infection is associated with severe clinical disease and high morbidity in immunocompromised hosts. Letermovir and maribavir, are two recently developed antiviral drugs used in the prevention and treatment of resistant and refractory CMV. Following the publication of landmark randomized trials and increased use, both clinical trial data and real-world experience has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetates
Share to Antiviral Agents
Share to Benzimidazoles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Cytomegalovirus

Share to Cytomegalovirus Infections

Share to Drug Resistance, Viral

Share to Quinazolines

Source

Identifiers

PMID: 39331647
DOI: 10.1097/QCO.0000000000001065

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies.PMID 39331647Read ↗

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection.Semantic proximity Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

Approach to drug-resistant cytomegalovirus in transplant recipients.Semantic proximity Read ↗

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.Semantic proximity Read ↗

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.Semantic proximity Read ↗

Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infectionSemantic proximity Read ↗

Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance.Semantic proximity Read ↗

The biology of cytomegalovirus drug resistance.Semantic proximity Read ↗

Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.Semantic proximity Read ↗

Antiviral drug resistance.Semantic proximity Read ↗

Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.Semantic proximity Read ↗

Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.